MAPK7 and prostate carcinoma: The last treatment predicted by CancerOmicsNet of the human prostate cancer cell line DU 145 with the ERK5/BRD4 inhibitor XMD8-92 (prediction score of 0.79, Figure 3C) is effective only at the highest concentration of 10 μM.